Accession Number:



Treating Gulf War Illness with Novel Anti-Inflammatories: A Screening of Botantical Microglia Modulators

Descriptive Note:

Technical Report,30 Sep 2014,29 Sep 2015

Corporate Author:

University of Alabama at Birmingham Birmingham United States

Personal Author(s):

Report Date:


Pagination or Media Count:



On June 30, 2015, we obtained final IRB approval and an IND exemption determination from UAB IRB. All approved documents consent form, human subject protocol and attachments were forwarded to ORP HRPO for final approval on July 2, 2015. While awaiting final ORP HRPO approval we have worked to establish collaborations with Birmingham and Alabama VA support groups for recruitment purposes. We have also established a great rapport with the nursing staff at the UAB Clinical Research Unit CRU where the study will be conducted. We have selected personnel to run the study and started training on the UAB IRB process, regulatory document preparation, review and submission. Upon the receipt of the final IRB ORP HRPO approval, we will initiate recruitment advertising, participant screening, enrollment and the study protocol.

Subject Categories:

Distribution Statement: